Cancer Medicines
Spending on cancer medicines increased 11.5 percent to $107 billion worldwide in 2015, with projections that costs could exceed $150 billion by 2020.
The trend reflects adoption of newer, pricier therapies, according to a new IMS report.
Source: CNBC
